PTSD is hard to treat because it changes the brain, the body’s stress system, and even gene expression in ways that actively resist recovery. Even with the best available therapies, roughly 40% of patients still meet criteria for PTSD after completing a full course of treatment. That number reflects a disorder that isn’t just psychological. It’s a condition rooted in biology, reinforced by its own symptoms, and complicated by the other problems it tends to bring along.
Your Brain Rewires Its Threat System
PTSD is fundamentally a disorder of fear dysregulation. The brain circuit that processes threats, connecting the amygdala, hippocampus, and prefrontal cortex, is one of the most well-understood circuits in neuroscience. In PTSD, that circuit breaks down in a specific and frustrating way: the parts of the brain responsible for calming fear responses become underactive, while the parts that detect and amplify threats become overactive.
The prefrontal cortex normally acts like a brake on fear. It helps you assess a situation, recognize you’re safe, and dial down the alarm. In people with PTSD, two key areas of the prefrontal cortex show decreased activation when exposed to stressful or trauma-related cues. Meanwhile, brain regions involved in threat detection ramp up their activity. This imbalance means the brain struggles to do something called extinction recall, the process of learning that a previously dangerous cue is now safe. That’s exactly what therapy tries to accomplish, and the biology of PTSD works against it.
This isn’t just about reacting to trauma reminders. Research shows that people with PTSD also have reduced activity in the prefrontal cortex during basic tasks involving behavioral inhibition, like stopping a response in a simple computer game. The impairment extends to general cognitive control, which makes it harder to engage with the mental work therapy requires.
The Stress Hormone System Runs Backward
You might expect PTSD to involve chronically elevated stress hormones, but the reality is more counterintuitive. People with PTSD typically have lower cortisol levels than healthy controls, measured in saliva, urine, and blood. At the same time, their brains produce elevated levels of corticotropin-releasing hormone, the chemical that kicks off the stress response. The signal to be stressed is loud, but the body’s ability to follow through with a normal cortisol response is dampened.
The explanation lies in a feedback loop gone wrong. PTSD patients develop an increased number of highly sensitive cortisol receptors in the brain. Even small amounts of cortisol are enough to trigger the “off switch” for the stress response, keeping cortisol levels artificially low. This enhanced negative feedback means the system never fully completes a normal stress cycle. The brain stays in a state of heightened vigilance without the hormonal resolution that would normally follow. This persistent dysregulation fuels the hyperarousal, sleep disruption, and emotional reactivity that make daily functioning difficult and therapy harder to sustain.
Avoidance Fights Treatment at Every Step
Avoidance is a core symptom of PTSD, but it’s also the single biggest obstacle to treatment. The most effective therapies for PTSD, including prolonged exposure and cognitive processing therapy, require patients to confront traumatic memories and the emotions attached to them. Avoidance is the opposite of that. It’s the impulse to stay away from anything that triggers distress, and in PTSD it becomes a deeply ingrained cognitive pattern.
Research shows that people with PTSD symptoms acquire avoidance behaviors faster and more strongly than people without PTSD, even in tasks that have nothing to do with trauma or fear. In one study, participants with PTSD symptoms learned avoidance patterns more quickly during a simple computer game with no emotional content at all. This suggests avoidance in PTSD isn’t limited to trauma reminders. It becomes a general cognitive bias, a default way of processing the world that steers people away from discomfort of any kind. That bias directly undermines therapy, where facing discomfort is the mechanism of healing.
Nearly Half of Patients Have a Substance Use Problem Too
PTSD rarely travels alone. Among people with PTSD, nearly half (46.4%) also meet criteria for a substance use disorder, and more than one in five meet criteria for substance dependence specifically. People with PTSD are two to four times more likely to develop a substance use problem than people without it, and some studies put that figure as high as 14 times more likely.
This combination is more than the sum of its parts. People dealing with both PTSD and substance use have more chronic physical health problems, worse social functioning, higher rates of suicide attempts, more legal problems, and an increased risk of violence compared to people with either condition alone. They also show worse treatment adherence and less improvement during therapy. The substance use often serves as a form of self-medication, numbing the hyperarousal and intrusive memories that PTSD produces. But it also disrupts the cognitive and emotional processing that therapy depends on, creating a cycle where each condition reinforces the other.
Among veterans who served from the Vietnam era onward, 41.4% of those with a substance use disorder were also diagnosed with PTSD. In civilian treatment settings for substance use, lifetime PTSD rates range from 30% to over 60%. These aren’t edge cases. Co-occurring conditions are the norm, not the exception, and they make treatment planning significantly more complex.
Treatment Works, but Not for Everyone
The first-line therapies for PTSD, cognitive behavioral approaches like prolonged exposure and cognitive processing therapy, are genuinely effective. But a meta-analysis looking across dozens of studies found a weighted average nonresponse rate of 39.23%. That means about four in ten patients who complete treatment still meet diagnostic criteria for PTSD afterward. Cognitive processing therapy had a nonresponse rate of 47.52%, prolonged exposure came in at 39.60%, and EMDR showed a slightly lower rate of 31.71%.
Dropout compounds the problem. On average, about 20% of patients leave trauma-focused therapy before finishing. Younger patients and those living alone are more likely to drop out. The reasons connect back to the disorder itself: avoidance makes it painful to continue, sleep disruption saps the energy and cognitive capacity needed for sessions, and the emotional intensity of confronting traumatic memories can feel unbearable in the short term, even when it leads to improvement in the long term.
Complex Trauma Adds Layers of Difficulty
Not all PTSD looks the same. People who experienced prolonged, repeated trauma, especially in childhood or in the context of relationships, often develop what the World Health Organization now recognizes as complex PTSD. Beyond the standard symptoms of re-experiencing, avoidance, and hyperarousal, complex PTSD includes significant difficulties with emotional regulation, self-concept, and relationships. People with this form describe taking a very long time to calm down when upset, feeling emotionally numb or shut down, seeing themselves as a failure or worthless, and feeling cut off from other people.
These additional symptoms interfere with the therapeutic relationship itself. If you struggle to trust people, feel fundamentally damaged, and can’t tolerate intense emotions, sitting in a room with a therapist and processing your worst memories is an enormous ask. This is why many clinicians argue that complex PTSD requires a phased approach: first building safety, emotional skills, and a therapeutic alliance, then moving into trauma processing, and finally working toward a life less defined by trauma’s consequences. That phased approach takes considerably longer than standard protocols, which typically run 8 to 16 sessions.
Trauma Changes Gene Expression
One of the more unsettling discoveries in PTSD research is that trauma doesn’t just change how you feel or how your brain functions. It changes how your genes are expressed. Epigenetic alterations, changes that turn genes on or off without altering the DNA itself, play a significant role in PTSD susceptibility, symptom severity, and long-term outcomes.
Researchers have identified specific changes in DNA methylation (a process that silences or activates genes) appearing as early as three months after a traumatic event. In one study, people with PTSD showed significant changes in the methylation of 28 genes compared to controls, with some genes becoming more active and others less so. Other research found that decreases in methylation of a specific gene after military deployment were associated with the emergence of PTSD symptoms. These aren’t abstract findings. They help explain why PTSD can become more entrenched over time and why some people are biologically more vulnerable to developing it in the first place.
Notably, some of these epigenetic changes shift during treatment, suggesting the biology isn’t permanently fixed. But the fact that trauma can alter gene expression at all underscores why PTSD isn’t something people can simply decide to get over. The disorder embeds itself in the body’s most fundamental regulatory systems, making recovery a biological process as much as a psychological one.
Sleep Disruption Undermines Recovery
Sleep problems are among the most common and persistent symptoms of PTSD, and they don’t just make people tired. Sleep plays a critical role in emotional processing and memory consolidation. When sleep is fragmented, the brain loses its ability to process emotional experiences during REM sleep, which is exactly the kind of processing that helps trauma memories become less distressing over time. Some researchers have proposed that treating insomnia before starting trauma-focused therapy could improve outcomes by restoring the sleep-dependent processes that therapy relies on. Sleep apnea, which is also more common in people with PTSD, further fragments REM sleep and compounds the problem.
The result is a vicious cycle: PTSD disrupts sleep, poor sleep impairs the brain’s ability to process trauma, and impaired processing keeps PTSD symptoms active. Breaking that cycle often requires addressing sleep as its own treatment target rather than assuming it will resolve once PTSD improves.